Introduction {#S1}
============

Larynx carcinoma accounts for 4.5% of malignant neoplasms and glottic cancer makes up approximately 50% of laryngeal tumours [@R01]. Different options are available for treatment, especially when the tumour is identified at an early stage: transoral laser microsurgery (TLM), open partial laryngectomy (OPL) and radiotherapy (RT) [@R02] [@R03].

In the last years the use of TLM has greatly expanded. For this reason, it has been debated whether the oncological and functional results of this method are comparable to those of other techniques. OPL allows obtaining larger free margins and better oncological results; it also gives the possibility to treat the neck simultaneously, when required. On the other hand, hospitalisation times are longer, the rate of complications is higher and functional results are worse [@R04].

RT is associated with good oncological outcome, but higher costs and longer time of care; the voice is generally good at the end of treatment [@R05].

TLM can be used to manage Tis, T1, T2 and selected T3 glottic cancers [@R06] [@R07]. Hospitalisation time is reduced to 1-3 days on average (depending on the type of cordectomy); oncological and functional results are usually good if an experienced surgical team performs the procedure.

In this paper, we analyse our experience in TLM in terms of oncological outcomes. Different prognostic factors were analysed to identify specific tumour features that are related to poor prognosis.

Materials and methods {#S2}
=====================

The study was carried out retrospectively on a series of 72 patients with T1-T2 glottic cancer treated with CO2 laser-assisted endoscopic cordectomy (TLM) between February 2006 and February 2012 at the ENT department of San Raffaele Hospital in Milan, Italy. The original cohort included 120 cases, but we excluded patients who did not reach a minimum 36-month follow-up period (57.4 ± 20.2 months). Forty-eight patients had shorter follow-up period or, alternatively, were missed during the follow-up. The cohort included 66 men (91.7%) and 6 women (8.3%) with a mean age of 65 (range: 35-87) at the time of surgery. No patient had received previous treatment for laryngeal cancer.

All patients underwent pre-operative white light and NBI video-laryngoscopy with flexible endoscope and videolaryngo- stroboscopy. Patients with manifest involvement of anterior commissure, Morgagni\'s ventricle, subglottis, arytenoids, or with impaired vocal fold mobility underwent contrast-enhanced neck computed tomography (CT) that helped rule out paraglottic space invasion or cartilage infiltration, which would contraindicate TLM. They were also evaluated with angled telescopes (0°, 30°, 70°) immediately before surgery to better explore those critical subsites. According to TNM classification of the Union Internationale Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC) (7th edition) [@R08], clinical staging of primary laryngeal lesions (cT) was cT1a in 61 cases (84.7%), cT1b in 3 cases (4.2%) and cT2 in 8 cases (11.1%). No regional lymph node metastases (N) were detected at diagnosis, either clinically or with CT.

All surgical procedures were performed under general anaesthesia after oro-tracheal intubation. Tumour excision under microlaryngoscopy was always performed with a Lumenis AcuPulse 30ST CO2 laser (Lumenis Ltd. Yokneam, Israel) with super pulse beam delivery and power tailored on the target structures (4 W for vestibulectomy, 1.5-2 W for cordectomy). Endoscopic resections were graded according to the European Laryngological Society Classification [@R09] and its more recent revision [@R10], including 6 types of cordectomy: subepithelial (type I), subligamental (type II), transmuscular (type III), total (type IV), extended (type V) and the latest anterior commissurectomy with bilateral anterior cordectomy (type VI). As far as type III cordectomy was concerned, excision had both diagnostic and therapeutic aim. When deeper resections were indicated, patients achieved pathological diagnosis of lesions with bioptic microlaryngoscopy under general anaesthesia and all available therapeutic options were discussed, focusing on oncological and functional outcomes linked with each procedure.

Endoscopic resections were carried out with an en-bloc or piece-meal technique according to tumour location, extension on glottic surface and ease of laryngeal exposure. No elective neck dissection was performed. In order to evaluate both deep and superficial resection margins, surgical specimens were sent to a dedicated pathologist with a clearly inked margin. A detailed diagram of the surgical procedure was sent together with the specimen in case of piece-meal excision with critical margins specifically indicated.

Resection margins were classified as free, positive (superficial or deep), or unassessable (due to surgical artefacts). In case of a single superficial positive margin, our policy was to assign patients to a careful follow-up since resection margins were approached by photovaporisation. In particular, patients were followed up with monthly endoscopic controls and periodical neck CT evaluation. Patients with deep positive margin underwent revision TLM. Patients with free margins were assigned to 3-month endoscopic follow-up during the first two years, which was increased to 6 months during the third year. No patients underwent RT because of involved resection margins.

Statistical analysis was performed with the SPSS statistical package. The log-rank test and the Kaplan-Meier survival function were applied to assess different diseasefree survival (DFS) rates for patients stratified according to variables of interest. Same variables were assessed with regards to recurrence rates with a chi-squared test. A p \< 0.05 was considered statistically significant.

Results {#S3}
=======

Nine patients underwent type I cordectomy (12.5%), 14 patients type II (19.4%), 20 patients type III (27.8%), 12 patients type IV (16.7%) and 17 patients type V (23.6%). No type VI cordectomy was performed in our sample since no tumour originating from the anterior commissure was detected. En-bloc resection was preferred in 69 cases (95.8%), while a piece-meal technique was performed in only 3 cases (4.2%).

Median hospitalisation time was 3 days (range: 1-20 days). In particular, patients who underwent type I, II and III cordectomy were discharged on the first postoperative day, while deeper resections generally required hospitalization for 3 days. Longer hospital stay was associated with postsurgical complications.

Tumour staging according to pathological examination (pT) was pTis in 8 cases (11.1%), pT1a in 53 cases (73.6%), pT1b in 2 cases (2.8%) and pT2 in 9 cases (12.5%). Anterior commissure was involved in 19 patients (26.4%), vocal muscle in 17 patients (23.6%) and supraglottic structures (Morgagni\'s ventricle, false vocal cord) in 9 patients (12.5%). Resection margin status showed 38 cases with free margins (52.8%), 13 cases with a single superficial positive margin (18.1%), 7 cases with deep positive margin (9.7%) and 14 cases with unassessable margins due to surgical artefacts (19.4%). No surgical specimens with multiple superficial positive margins were detected.

Major and minor procedure-related complications are common in this kind of surgery. Major complications are defined as those that need extended medical therapies, blood transfusions, early surgical revision, or intensive care unit recovery. Two patients (2.8%) required nasogastric tube insertion to avoid inhalation, while 5 cases (6.9%) underwent prophylactic tracheostomy. All tracheostomies were closed before discharge. No intra-operative complications were reported. Four patients (5.6%) experienced early complications related to the surgical procedure: one case of limited post-operative laryngeal bleeding not requiring surgical haemostasis (1.4%), 2 cases of aspiration pneumonia (2.8%) and one subcutaneous cervical emphysema (1.4%). None required early surgical intervention. Late complications affected 8 patients in our cohort (11.9%): 3 cases of anterior glottic synechia (4.5%) and 5 cases of vocal cord granulomas (7.5%). The latter reported to chronically suffer from reflux-induced laryngitis: at first they were treated with proton-pump inhibitors and logopaedic therapy but later endoscopically excised, since none resolvedwith conservative treatment.

Recurrence is conventionally defined as a biopsy-proven neoplastic lesion in patients treated with TLM less than 60 months prior [@R11]. Since our study evaluated the first three years after surgical procedure, relapse was defined within the period considered. Recurrence occurred in 11 patients (15.3%) after a mean of 16.8 ± 8.9 months. Ten patients experienced a local recurrence (13.9%): 5 cases underwent salvage TLM (one type II cordectomy, one type III and three type V), 2 patients were treated with RT, 1 with supracricoid OPL and 2 with total laryngectomy followed by adjuvant RT. Two of these patients experienced a second recurrence: both were treated with concomitant chemo-RT. One patient developed cervical lymph node involvement (1.4%) demonstrated by positive fine-needle aspiration cytology (FNAC) and underwent selective ipsilateral neck dissection (Robbins level II-IV [@R12]. One patient died of disease (1.4%), while 8 patients died for unrelated causes (11.1%).

[Table I](#T1){ref-type="table"} shows the recurrence rate and DFS stratified according to common variables of interest: cT or pT staging, involvement of anterior commissure, supraglottis or vocal muscle, type of cordectomy and resection margin status. Statistical analysis highlighted substantial correlation between pT staging or anterior commissure involvement and recurrence (p = 0.035 and p = 0.021, respectively), as displayed in [Figures 1](#F1){ref-type="fig"} and [2](#F2){ref-type="fig"}. Moreover, neoplastic extension to the anterior commissure appears to adversely influence DFS (p = 0.017, [Fig. 3](#F3){ref-type="fig"}) as does pT staging (p = 0.023, [Fig. 4](#F4){ref-type="fig"}). None of the other parameters reached statistical significance.

###### 

Recurrence rates and disease-free survival (DFS; mean ± standard deviation) stratified according to variables of interest.

  Variable                                                      No. of cases   Recurrence rates   p value [^a^](#T1FN1){ref-type="table-fn"}   DFS in months (mean ± SD)   p value [^b^](#T1FN2){ref-type="table-fn"}
  ------------------------- ----------------------------------- -------------- ------------------ -------------------------------------------- --------------------------- --------------------------------------------
  cT                        cT1a                                61             8/61 (13.1%)       0.230                                        33.7 ± 6.8                  0.198
                            cT1b-cT2                            11             3/11 (27.3%)                                                    29.7 ± 11.4                 
  pT                        pTis-pT1a                           61             7/61 (11.5%)       0.035                                        34.0 ± 6.3                  0.023
                            pT1b-pT2                            11             4/11 (36.4%)                                                    27.7 ± 12.1                 
  Anterior commissure       Free                                53             5/53 (9.4%)        0.021                                        34.3 ± 6.2                  0.017
                            Involved                            19             6/19 (31.6%)                                                    29.7 ± 10.4                 
  Supraglottis              Free                                63             8/63 (12.7%)       0.108                                        33.6 ± 7.0                  0.094
                            Involved                            9              3/9 (33.3%)                                                     29.0 ± 11.2                 
  Vocal muscle              Free                                55             8/55 (14.5%)       0.756                                        33.2 ± 7.7                  0.760
                            Involved                            17             3/17 (17.6%)                                                    32.6 ± 8.0                  
  Cordectomy                Type I                              9              2/9 (22.2%)        0.561                                        34.3 ± 4.3                  0.600
                            Type II                             14             3/14 (21.4%)                                                    31.3 ± 10.2                 
                            Type III                            20             3/20 (15.0%)                                                    32.7 ± 8.3                  
                            Type IV                             12             0/12 (0%)                                                       36.0 ± 0                    
                            Type V                              17             3/17 (17.6%)                                                    32.2 ± 8.8                  
                            Superficial (type I, II, III)       43             8/43 (18.6%)       0.339                                        32.6 ± 8.3                  0.353
                            Deep (type IV, V)                   29             3/29 (10.3%)                                                    33.8 ± 6.9                  
  Resection margin status   Free                                38             4/38 (10.5%)       0.250                                        34.8 ± 3.8                  0.193
                            Single superficial positive         13             1/13 (7.7%)                                                     33.9 ± 7.5                  
                            Deep positive                       7              2/7 (28.6%)                                                     28.0 ± 13.7                 
                            Unassessable (surgical artifacts)   14             4/14 (28.6%)                                                    30.0 ± 10.6                 

Chi-squared test;

Log-rank test;

cT = clinical staging; pT = pathological staging

![Bar chart showing 3-year recurrence rates according to pT stage (p = 0.035).](0392-100X-36-167-g001){#F1}

![Bar chart showing 3-year recurrence rates according to anterior commissure involvement (p = 0.021).](0392-100X-36-167-g002){#F2}

![Kaplan-Meier survival curves stratified according to pT stage (p = 0.023).](0392-100X-36-167-g003){#F3}

![Kaplan-Meier survival curves stratified according to anterior commissure involvement (p = 0.017).](0392-100X-36-167-g004){#F4}

Discussion {#S4}
==========

Early stage glottic cancer can be managed by OPL, RT or TLM. All these methods are associated with good oncological results. For this reason, the choice of treatment should be related to costs, time of hospitalisation, rate of complications and functional results, although the patients\' will must be considered first. In fact, there are no prospective randomised clinical trials assessing long-term outcomes associated with these different techniques.

As a general rule, early stage laryngeal tumours should be approached by a single modality of treatment [@R13] [@R14]. This allows preserving the chance of a second, different treatment in case of relapse and also provides better functional results, since combined approaches (TLM followed by RT) are always associated with worse functional outcome. In our cohort, laryngeal tumour was more common in men than in women (male-female ratio 8:1), as is well known in the ENT literature [@R15]. This can be largely explained by higher rates of smoking and alcohol assumption in men. Mean age at the time of surgery (65 years) was also similar to those described by other authors [@R16]. Hospital stay was influenced by type of cordectomy and postoperative complications, as discussed above. Day surgery was generally enough for patients who underwent type I, II and III cordectomy, while deeper resections often required longer stays. Three days was the mean hospitalisation time in type IV and V cordectomy, even though post-surgical complications usually increased hospital stay.

Early postoperative complications generally include subcutaneous emphysema, bleeding, dyspnoea, dysphagia, aspiration pneumonia and laryngo-cutaneous fistula. Subcutaneous emphysema is mainly associated with cricothyroid membrane perforation. This can occur when glottic tumours extend beyond the inferior margin of thyroid cartilage or in commissural lesions in which oncologically- safe resection need to overcome that border [@R17]. Only 1 patient (1.4%) suffered from subcutaneous emphysema in our cohort; conservative management allowed its resolution before hospital discharge, as stated by Steiner in his assessment of postoperative complications after laser surgery of tumours of the upper aerodigestive tract [@R18]. In a previous work, Steiner and Ambrosch reported the incidence of post-surgical bleeding to be 7% in supraglottic partial laser-assisted endoscopic resections, 3% in hypopharyngeal ones and 0% in glottic ones [@R19]. One case in our cohort experienced this postoperative complication, and the haemorrhage stopped without surgical haemostasis. Aspiration pneumonia occurs most frequently in surgical treatment of supraglottic (5.8%) or hypopharyngeal cancers (12.9%) than in glottic tumours (1.7%) [@R20]. Two patients suffered from this complication within our cohort (2.8%), which is consistent with most of the ENT literature. The rate of postoperative dysphagia is obviously influenced by extension of surgical resection: only 2 patients (2.8%) required nasogastric tube insertion to avoid inhalation.

One of the greatest advantages of TLM compared to OPL is the reduced need for prophylactic tracheostomy [@R21]. The study by Preuss reported a rate of prophylactic tracheostomy among patients who underwent TLM for laryngeal cancer of 1.9% [@R22]. As a general rule, our policy is to resort to tracheostomy in patients with a high risk of post-surgical endolaryngeal oedema or bleeding (patients taking anticoagulants or with significant intraoperative haemorrhage). In our cohort, 5 cases (6.9%) underwent prophylactic tracheostomy and all were closed before hospital discharge. However, dividing the temporal range (2006-2012), 4 tracheostomies were performed in the first half (2006-2009), compared to just 1 in the second interval (2009-2012), suggesting a clear decreasing trend. This can be explained with an improved intra- and postoperative management of patients associated with the physiological, surgical learning curve and the low rate of postoperative complications. This is highlighted by Vilaseca: in his investigation the post-surgical complication rate drastically reduced with increasing surgical expertise [@R23].

Late postoperative complications normally consist of anterior glottic synechia, vocal cord granulomas and arytenoid oedema. Anterior glottic synechiae are clinically relevant since they shrink the laryngeal respiratory space, although they can ease post-surgical glottic adduction and improve vocal outcome. That is why excision is considered only in case of substantial dyspnoea. In our cohort, 3 patients experienced anterior glottic synechia (4.2%) and none underwent surgical intervention. Vocal cord granulomas arise when endoscopic resection reaches inner perichondrium, especially in patients with a history of gastro-oesophageal reflux disease. Five of our patients developed granulomas (6.9%) and all referred to chronically suffer from reflux-induced laryngitis. Proton-pump inhibitor therapy combined with logopaedic rehabilitation did not achieve resolution in any of the affected patients, and they underwent endoscopic excision of granulomas. Arytenoid oedema can cause dyspnoea and dysphagia. In these cases, photovaporisation of the oedematous mucosa by CO2 laser can be useful, and was required by two patients in our cohort (2.8%).

The incidence of laryngeal tumour relapse after TLM was studied for the first time by Steiner and Ambrosch [@R19]. They reported a relapse rate of 9.5% in stage I and II and 19.5% in stage III and IV. Herein, the recurrence rate was 15.3% (11 cases) and a disease-specific survival rate of 98.6% was seen, with a preservation rate of 97.2%. These results are similar to those described by Lucioni [@R24].

Accurate preoperative staging allows good correspondence between clinical and postoperative definition of the tumour and can help to predict recurrence. Pre-operative white light and NBI video-laryngoscopy with flexible endoscope, video-laryngo-stroboscopy, imaging assessment (CT, MRI) and intraoperative evaluation with angled telescopes (0°, 30°, 70°) are all tools for such a purpose. Recently, even direct autofluorescence during intraoperative work-up has been shown to be useful [@R25]. In our study, we found no statistical significance in the association between relapse and clinical staging (p = 0.230), while pathological staging showed a clear correlation with the incidence of recurrence (p =†0.035). The same evidence was noted with regards to DFS shrinkage (p = 0.198 and p = 0.023 for cTNM and pTNM, respectively). This difference can be easily explained by the pathological upstaging that occurred in some cases: Ansarin has already highlighted this possibility [@R26].

We also found that anterior commissure involvement was related to a higher rate of recurrence (p = 0.021) with a lower DFS (p = 0.017). Since the recent introduction of type VI cordectomy [@R10], a pure commissural tumour can be treated in a single session, offering better disease control compared to two-stage bilateral cordectomy. However, this latter technique can be still adopted in case of T1b glottic tumours. Considering T1b tumours, indeed, Roedel found reduced local control with TLM, evidence that was not confirmed in T2 neoplasms with anterior commissure involvement (transcommissural tumours). Moreover, in his experience T1b cancers and anterior commissure involvement in T2 transcommissural tumours did not show a substantial reduction in disease-specific survival [@R27]. On the other hand, Blanch observed that anterior commissure involvement influenced both relapse rate and disease-specific survival [@R28].

No significant difference was found between vocal muscle or supraglottic involvement and rate of recurrence (p = 0.756 and p = 0.108, respectively), as these subsites can be easily controlled by TLM.

Although no cases of arytenoid or subglottic region involvement were detected, a higher recurrence rate is associated with tumour extension to those laryngeal subsites [@R24]; different distribution of submucosal lymphatic drainage within the larynx largely justifies this finding.

A margin of 1 mm is considered oncologically safe in glottic TLM [@R26]. However, the relationship between resection margin status and relapse rate is still controversial [@R29]^-^[@R31]. As a general rule, we recommend strict follow-up when a superficial margin is given as involved by pathologists. Instead, when a deep margin is involved we usually perform a revision TLM within a few weeks.

Conclusions {#S5}
===========

TLM in early stage glottic cancer shows several advantages compared to RT and to OPL, such as reduced intra- and postoperative morbidity and shorter time of care. To date, we consider TLM as the treatment of choice in T1a, T1b and selected T2 and T3 tumours. In fact, it elicits no changes in swallowing and allows preservation of physiological respiration. Early complications are usually manageable without surgery and decrease with increasing surgical experience; on the other hand, late complications frequently need revision procedures, in most cases endoscopically.

TLM shows good results in terms of DFS and OS, comparable to those of RT. The relapse rate is higher (p = 0.021 and p = 0.035) and DFS is lower (p = 0.017 and p = 0.023) when anterior commissure is involved or pT is concerned, respectively. Type of cordectomy, cT, supraglottic or vocal muscle involvement and resection margin status do not significantly impact the recurrence rate.
